Know The Truth

...and be set FREE!

What is THE TRUTH?


IVERMECTIN – an Effective Treatment for COVID

Dr. John Campbell – Ivermectin Evidence with Dr Tess Lawrie


Evaluation of Ivermectin as an Effective Prophylactic, and for Treatment in Hospitalized Patients with COVID-19

Ivermectin and Covid-19 Treatment

A five-day course of Ivermectin for the treatment of COVID-19 may reduce the duration of illness

Source of (animal) Ivermectin in Canada

COVID-19 Life Saving Treatments

Early COVID Treatment Works

  1. A Comparative Study on Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin Therapy on COVID-19 Patients, Abu Taiub Mohammed Mohiuddin Chowdhury, Mohammad Shahbaz, Md Rezaul Karim, Jahirul Islam, Guo Dan, Shuixiang He
  2. Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study, Matthew S Freiberg, et al
  3. Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial, Reaz, Mahmud, Rahman, Mujibur, Iftikher, Alam, Ahmed, Kazi Gias Uddin, Kabir, A. K. M. Humayon, S. K. Jakaria Been, Mohammad Aftab, Mohammad Monirul, Anindita Das, Mohammad Mahfuzul, Mohammad Abdullah, Mohammad Zaid
  4. The Role of Steroids in the Management of COVID-19 Infection
    Zayar Lin, Wai Hnin Phyu, Zin Hnin Phyu, and Tin Zar Mon
  5. Antithrombotic Therapy to Ameliorate Complications of COVID-19, Brett L Houston et al
  6. COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study, Roland Derwand, Martin Scholz, Vladimir Zelenko
  7. Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19, Saiful Islam Kha, Sakirul Islam Khan, Chitto Ranjan Debnath, Progga Nanda Nath, Mamun Al Mahtab, Hiroaki Nabeka, Seiji Matsuda, Sheikh Mohammad Fazle Akbar
  8. Ivermectin and the odds of hospitalization due to COVID-19: evidence from a quasi-experimental analysis based on a public intervention in Mexico City, Jose Merino, Victor Hugo Borja, Oliva Lopez, José Alfredo Ochoa, Eduardo Clark, Lila Petersen, Saul Caballero
  9. Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India, Ravikirti, Roy, R., Pattadar, C., Raj, R., Agarwal, N., Biswas, B., Manjhi, P. K., Rai, D. K., Shyama, Kumar, A., & Sarfaraz, A.
  10. Hydroxychloroquine for prophylaxis and treatment of COVID-19 in health-care workers, Simova T., Vekov J., Krasnaliev V., Kornovski P., Bozhinov
  11. Efficacy of a Low Dose of Melatonin… in Hospitalized Patients with COVID-19, GholamHossein Alishiri
  12. The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19 Yaseen M. Arabi, George P. Chrousos & G. Umberto Meduri
  13. Early short course corticosteroids in hospitalized patients with COVID-19 (Multi-center quasi-experimental study), Mayur S. Ramesh et al.
  14. Doxycycline and Hydroxychloroquine as Treatment for High-Risk COVID-19 Patients: Experience from Case Series of 54 Patients in Long-Term Care Facilities, Ahmad I. et al.
  15. Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19. A Randomized Clinical Trial, Lenze E. et al.
  16. Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study, Di Pierro F. et al.
  17. Antivirals With Adjunctive Corticosteroids Prevent Clinical Progression of Early Coronavirus 2019 Pneumonia: A Retrospective Cohort Study, Ooi ST et al.
  18. Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients, Carlucci P. et al.
  19. SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels, Kaufman H. et al.
  20. Hydroxychloroquine and Azithromycin Treatment of Hospitalized Patients Infected with SARS-CoV-2 in Senegal from March to October 2020, Taieb F. et al.
  21. Doxycycline and Hydroxychloroquine as Treatment for High-Risk COVID-19 Patients: Experience from Case Series of 54 Patients in Long-Term Care Facilities, Ahmad I. et al.
  22. Hydroxychloroquine in Early Treatment of High-Risk COVID-19 Outpatients: Efficacy and Safety Evidence, Risch, Harvey.
  23. Metaanalyses and Aggregated Ivermectin Studies – 1
  24. Metaanalyses and Aggregated Hydroxychloroquin Studies – 1
  25. Metaanalyses and Aggregated Ivermectin Studies – 2



Leave a Comment

Get New Posts in Your Inbox

Recent Posts


Contact Us

On Key

Related Posts